Minoxidil and Its Use in Hair Disorders: A Review [Corrigendum]
February 2020
in “
Drug Design Development and Therapy
”
TLDR Low-dose Minoxidil combined with Spironolactone helps reduce hair loss and improve hair density in women, with some mild side effects.
In 2020, a review on the use of Minoxidil in hair disorders was corrected to state that a combination of low-dose Minoxidil (0.25 mg, not 2.5 mg as previously stated) and Spironolactone (25 mg) in patients with Female Pattern Hair Loss (FPHL) showed positive outcomes, including decreased hair shedding and improved hair density. The mean reduction in hair shedding score was 2.3 at 6 months and 2.6 at 12 months. Mild side effects such as urticaria, postural hypotension, and facial hypertrichosis were reported. The correction also clarified that the reduction in severity score relates to the visual-analogue Sinclair hair shedding scale.
